Amyris hits jackpot with $255m deal for cannabinoid development

The CBD cosmetic ingredient is gaining widespread traction across the beauty category as more governments relax rule on its consumption

Sustainable ingredients producer Amyris has landed a multi million dollardeal to develop and commercialise cannabinoid products.

The $255m agreement includes . . .

This is a small extract of the full article which is available ONLY to premium content subscribers. Subscribers sign-in (top right) to read the article.


Subscribe now to premium content on Cosmetics Business